To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Odyssey-backed ProPharma acquires Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a provider of regulatory affairs, pharmacovigilance, and compliance and quality services for pharmaceutical and biotechnology companies.
